SCI Pharmtech Inc
TWSE:4119
SCI Pharmtech Inc
Free Cash Flow
SCI Pharmtech Inc
Free Cash Flow Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
Company | Free Cash Flow | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
---|---|---|---|---|---|---|
S
|
SCI Pharmtech Inc
TWSE:4119
|
Free Cash Flow
-NT$696.9m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-41%
|
|
Y
|
YungShin Global Holding Corp
TWSE:3705
|
Free Cash Flow
NT$1.1B
|
CAGR 3-Years
4%
|
CAGR 5-Years
58%
|
CAGR 10-Years
5%
|
|
![]() |
Formosa Laboratories Inc
TWSE:4746
|
Free Cash Flow
NT$226.1m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
![]() |
ScinoPharm Taiwan Ltd
TWSE:1789
|
Free Cash Flow
NT$339.9m
|
CAGR 3-Years
-3%
|
CAGR 5-Years
-18%
|
CAGR 10-Years
N/A
|
|
![]() |
Lotus Pharmaceutical Co Ltd
TWSE:1795
|
Free Cash Flow
NT$3.3B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
![]() |
Standard Chem & Pharm Co Ltd
TWSE:1720
|
Free Cash Flow
NT$1.1B
|
CAGR 3-Years
13%
|
CAGR 5-Years
18%
|
CAGR 10-Years
18%
|
SCI Pharmtech Inc
Glance View
SCI Pharmtech Corp. is engaged in the biotechnology and medical care industry. The company is headquartered in Taoyuan, Taoyuan. The company went IPO on 2002-08-12. The firm's main products include APIs, API intermediates and special and precision chemicals. The firm distributes its products in domestic market and to overseas markets, including Europe, the Americas, the rest areas of Asia and others
See Also
What is SCI Pharmtech Inc's Free Cash Flow?
Free Cash Flow
-696.9m
TWD
Based on the financial report for Sep 30, 2024, SCI Pharmtech Inc's Free Cash Flow amounts to -696.9m TWD.
What is SCI Pharmtech Inc's Free Cash Flow growth rate?
Free Cash Flow CAGR 10Y
-41%
Over the last year, the Free Cash Flow growth was 13%.